Item Type | Name |
Concept
|
Migraine Disorders
|
Concept
|
Migraine with Aura
|
Concept
|
Migraine without Aura
|
Academic Article
|
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: a response.
|
Academic Article
|
Chronic migraine--classification, characteristics and treatment.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Migraine headache is present in the aura phase: a prospective study.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
|
Academic Article
|
Migraine genetics - a review: part I.
|
Academic Article
|
Migraine Genetics: Part II.
|
Academic Article
|
Is there a preferred triptan?
|
Academic Article
|
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
|
Academic Article
|
Cardiovascular tolerability and safety of triptans: a review of clinical data.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
|
Academic Article
|
DHE in the pharmacotherapy of migraine: potential for a larger role.
|
Academic Article
|
Central sensitization theory of migraine: clinical implications.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
|
Academic Article
|
Operational diagnostic criteria for chronic migraine: expert opinion.
|
Academic Article
|
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
|
Academic Article
|
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT.
|
Academic Article
|
Late-life migraine accompaniments: A narrative review.
|
Academic Article
|
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
|
Academic Article
|
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
|
Academic Article
|
Fremanezumab for the Preventive Treatment of Chronic Migraine.
|
Academic Article
|
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
|
Academic Article
|
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
|
Academic Article
|
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
|
Academic Article
|
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
|
Academic Article
|
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
|
Academic Article
|
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
|
Academic Article
|
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
|
Academic Article
|
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
|
Academic Article
|
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.
|
Academic Article
|
Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
|
Academic Article
|
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
|
Academic Article
|
Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders.
|
Academic Article
|
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
|
Academic Article
|
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
|
Academic Article
|
Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology.
|
Academic Article
|
The Sinus, Allergy and Migraine Study (SAMS).
|
Academic Article
|
Atypical age-related cortical thinning in episodic migraine.
|
Academic Article
|
Adherence to oral migraine-preventive medications among patients with chronic migraine.
|
Academic Article
|
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
|
Academic Article
|
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
|
Academic Article
|
Duration of migraine is a predictor for response to botulinum toxin type A.
|
Academic Article
|
Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
|
Academic Article
|
Imploding and exploding migraine headaches: comparison of methods to diagnose pain directionality.
|
Academic Article
|
Response to Letter to the Editor.
|
Academic Article
|
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis.
|
Academic Article
|
Clinical, anatomical, and physiologic relationship between sleep and headache.
|
Academic Article
|
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
|
Academic Article
|
Proposed new diagnostic criteria for chronic migraine.
|
Academic Article
|
Site of effect of LY2951742 for migraine prophylaxis--authors' reply.
|
Academic Article
|
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
|
Academic Article
|
Diagnosis and treatment of migraine.
|
Academic Article
|
Extracephalic cluster (cluster sine headache).
|
Academic Article
|
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective.
|
Academic Article
|
Googling migraine: A study of Google as an information resource of migraine management.
|
Academic Article
|
Identifying migraine in primary care settings.
|
Academic Article
|
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
|
Academic Article
|
Vascular safety of erenumab for migraine prevention.
|
Academic Article
|
Sporadic hemiplegic migraine with permanent neurological deficits.
|
Academic Article
|
Sustained-release niacin for prevention of migraine headache.
|
Academic Article
|
Migraine with and without aura and risk for cardiovascular disease.
|
Academic Article
|
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis.
|
Academic Article
|
CGRP antagonists in the acute treatment of migraine.
|
Academic Article
|
Sumatriptan versus eletriptan: which is best?
|
Academic Article
|
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
|
Academic Article
|
The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
|
Academic Article
|
Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine.
|
Academic Article
|
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
|
Academic Article
|
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment.
|
Academic Article
|
Patent foramen ovale and migraine.
|
Academic Article
|
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
|
Academic Article
|
Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
|
Academic Article
|
A Phase-by-Phase Review of Migraine Pathophysiology.
|
Academic Article
|
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
|
Academic Article
|
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic.
|
Academic Article
|
Headache: challenging conventional wisdom.
|
Academic Article
|
Advanced neuroimaging of migraine.
|
Academic Article
|
Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
|
Academic Article
|
Ubrogepant for the Treatment of Migraine.
|
Academic Article
|
Migraine and risk of stroke.
|
Academic Article
|
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies.
|
Academic Article
|
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.
|
Academic Article
|
Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies?
|
Academic Article
|
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
|
Academic Article
|
Simvastatin for migraine prevention.
|
Academic Article
|
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
|
Academic Article
|
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM).
|
Academic Article
|
Headache research in 2015: progress in migraine treatment.
|
Academic Article
|
The Non-Inferiority Margins in Migraine Research (NIMM) Survey.
|
Academic Article
|
Identifying the factors underlying discontinuation of triptans.
|
Academic Article
|
Re: Placebo responses in device studies.
|
Academic Article
|
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
|
Academic Article
|
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research.
|
Academic Article
|
Advances in migraine management: implications for managed care organizations.
|
Academic Article
|
Best practices for patients with chronic migraine: burden, diagnosis, and management in primary care.
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
|
Academic Article
|
Pathophysiology and management of transformed migraine and medication overuse headache.
|
Academic Article
|
Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894.
|
Academic Article
|
The scientific basis of migraine.
|
Academic Article
|
Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache.
|
Academic Article
|
Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic.
|
Academic Article
|
Triptan nonresponder studies: implications for clinical practice.
|
Academic Article
|
Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literature.
|
Academic Article
|
Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.
|
Academic Article
|
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
|
Academic Article
|
Examining the essence of migraine--is it the blood vessel or the brain? A debate.
|
Academic Article
|
Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study.
|
Academic Article
|
Migraine.
|
Academic Article
|
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
|
Academic Article
|
Patent foramen ovale, stroke, and cardiovascular disease in migraine.
|
Academic Article
|
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
|
Academic Article
|
Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine.
|
Academic Article
|
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.
|
Academic Article
|
Functional MRI of migraine.
|
Academic Article
|
Migraine triggers.
|
Academic Article
|
The effect of prophylactic medications on TMS for migraine aura.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
|
Academic Article
|
Taking the headache out of migraine.
|
Academic Article
|
Migraine in special populations. Treatment strategies for children and adolescents, pregnant women, and the elderly.
|
Academic Article
|
Familial hemiplegic migraine: permanent attack-related neurologic deficits.
|
Academic Article
|
The face of chronic migraine: epidemiology, demographics, and treatment strategies.
|
Academic Article
|
Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings.
|
Academic Article
|
Migraine and the vascular system: much has been learned but still a long way to go.
|
Academic Article
|
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
|
Academic Article
|
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
|
Academic Article
|
Acute treatment patterns in patients with migraine newly initiating a triptan.
|
Academic Article
|
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
|
Academic Article
|
A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
|
Academic Article
|
Treatment of chronic migraine.
|
Academic Article
|
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
|
Academic Article
|
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving =50%, =75%, and 100% Response.
|
Academic Article
|
Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
|
Academic Article
|
Introduction: cardiovascular safety and triptans in the acute treatment of migraine.
|
Academic Article
|
Indomethacin-responsive headache syndromes.
|
Academic Article
|
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
|
Academic Article
|
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
|
Academic Article
|
Occipital Nerve Stimulation for Migraine: Update from Recent Multicenter Trials.
|
Academic Article
|
Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study.
|
Academic Article
|
Preventing migraine pharmacologically.
|
Academic Article
|
Clinical practice. Chronic daily headache.
|
Academic Article
|
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
|
Academic Article
|
Percutaneous occipital stimulator lead tip erosion: report of 2 cases.
|
Academic Article
|
Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
|
Academic Article
|
Duplicate publication.
|
Academic Article
|
Triptan-induced latent sensitization: a possible basis for medication overuse headache.
|
Academic Article
|
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
|
Academic Article
|
Transcranial magnetic stimulation for migraine: a safety review.
|
Academic Article
|
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
|
Academic Article
|
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
|
Academic Article
|
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
|
Academic Article
|
Epidemiology and acute care of migraine headache.
|
Academic Article
|
Current and emerging treatment options for migraine and other primary headache disorders.
|
Academic Article
|
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
|
Academic Article
|
Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
|
Academic Article
|
Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists.
|
Academic Article
|
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
|
Academic Article
|
Migraine: What Imaging Reveals.
|
Academic Article
|
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
|
Academic Article
|
Patent foramen ovale and migraine--bringing closure to the subject.
|
Academic Article
|
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache.
|
Academic Article
|
Triptan education and improving knowledge for optimal migraine treatment: an observational study.
|
Academic Article
|
The migraine landscape on YouTube: A review of YouTube as a source of information on migraine.
|
Academic Article
|
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
|
Academic Article
|
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
|
Academic Article
|
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
|
Academic Article
|
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
|
Academic Article
|
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing.
|
Academic Article
|
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
|
Academic Article
|
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
|
Academic Article
|
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial.
|
Academic Article
|
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
|
Academic Article
|
Effect of Migraine on Pregnancy Planning: Insights From the American Registry for Migraine Research.
|
Academic Article
|
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
|
Academic Article
|
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
|
Academic Article
|
Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.
|
Academic Article
|
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
|
Academic Article
|
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine Research.
|
Academic Article
|
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
|
Academic Article
|
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.
|
Academic Article
|
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
|
Academic Article
|
Systematic review of outcomes and endpoints in acute migraine clinical trials.
|
Academic Article
|
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
|
Academic Article
|
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials.
|
Academic Article
|
Systematic review of outcomes and endpoints in preventive migraine clinical trials.
|
Academic Article
|
Migraine: integrated approaches to clinical management and emerging treatments.
|
Academic Article
|
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey study.
|
Academic Article
|
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.
|
Academic Article
|
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
|
Academic Article
|
Mild traumatic brain injury affects the features of migraine.
|
Academic Article
|
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
|
Academic Article
|
Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome.
|
Academic Article
|
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
|
Academic Article
|
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
|
Academic Article
|
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.
|
Academic Article
|
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine.
|
Academic Article
|
Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
|
Academic Article
|
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials.
|
Academic Article
|
Diagnosing Secondary and Primary Headache Disorders.
|
Academic Article
|
Migraine.
|
Academic Article
|
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine.
|
Academic Article
|
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
|
Academic Article
|
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
|
Academic Article
|
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.
|
Academic Article
|
Treatment of chronic migraine with medication overuse: A perspective.
|
Academic Article
|
The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research.
|
Academic Article
|
Third gene identified for hereditary headache.
|
Academic Article
|
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention.
|
Academic Article
|
Sleep restriction alters cortical inhibition in migraine: A transcranial magnetic stimulation study.
|
Academic Article
|
Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men.
|
Academic Article
|
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
|
Academic Article
|
Exploring the association between migraine and atrial fibrillation utilizing a novel artificial intelligence-ECG algorithm.
|
Academic Article
|
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?
|
Academic Article
|
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.
|
Academic Article
|
Migraine research comes of age in the 21st century.
|
Academic Article
|
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain.
|
Academic Article
|
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence.
|
Academic Article
|
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.
|
Academic Article
|
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.
|
Academic Article
|
Patient-reported experiences with migraine-related cognitive symptoms: Results of the MiCOAS qualitative study.
|
Academic Article
|
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
|
Academic Article
|
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
|
Academic Article
|
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact.
|
Academic Article
|
Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).
|
Academic Article
|
Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of Migraine.
|
Academic Article
|
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees.
|
Academic Article
|
Prevalence of and Risk Factors for Post-traumatic Headache in Civilian Patients After Mild Traumatic Brain Injury: A TRACK-TBI Study.
|
Academic Article
|
Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache.
|